N Verses Capital, LLC Sana Biotechnology, Inc. Transaction History
N Verses Capital, LLC
- $41.7 Billion
- Q1 2024
A detailed history of N Verses Capital, LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 2,900 shares of SANA stock, worth $18,241. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,900Holding current value
$18,241% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding SANA
# of Institutions
155Shares Held
124MCall Options Held
297KPut Options Held
124K-
Flagship Pioneering Inc. Cambridge, MA25MShares$157 Million16.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$76.5 Million0.0% of portfolio
-
Baillie Gifford & CO10.7MShares$67 Million0.08% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$64 Million0.11% of portfolio
-
Black Rock Inc. New York, NY9.05MShares$56.9 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $1.2B
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...